https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai, India. Jean-marc Giboux | 3rd Party – Misc | Getty Images Stocks of leading Indian drugmakers fell on Friday, even though the 100% U.S. tariffs on branded and patented drug imports are unlikely to affect these companies. … Read more
Key Takeaways The SEC approved amendments allowing Grayscale’s Ethereum Trust and Mini Trust to be listed under NYSE Arca’s new generic Rule 8.201-E. The shift from non-generic to generic listing standards simplifies the process for Ethereum-based ETFs and signals broader market acceptance. Share this article The SEC has approved NYSE Arca’s proposal to transition Grayscale’s … Read more
With over 400 million chronic patients, India is one of the world’s largest medicine markets. But while most e-pharmacies chase speed, affordability remains the real challenge. Truemeds took a different route: helping patients switch to lower-cost substitutes, a bet now paying off with new funding at about four times its previous valuation. The six-year-old startup … Read more
Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is a major opportunity to show what affordable, high-quality weight loss care can look like,” said Andrew Dudum, co-founder and CEO of Hims & … Read more
Gov. Gavin Newsom has made California the first state to offer a generic version of the overdose-reversal drug Narcan for public purchase through a state-run storefront, while the state’s health department continues to promote a “Harm Reduction” model for the so-called “safe” use of drugs. “Life-saving medications shouldn’t come with a life-altering price tag,” Newsom … Read more
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Drugmaker Hikma is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents on Novo Nordisk’s blockbuster diabetes and weight loss drugs start expiring as … Read more
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4